Publications by authors named "Agnes Bellanger"

Claim this Profile
P
Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab.
Lina Jeantin, Natalia Shor, Marc Coustans, Damien Roos-Weil, Isabelle Quintin-Roué, Agnès Bellanger

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
Lina Jeantin, Natalia Shor, Maud Pallix-Guyot, Damien Roos-Weil, Agnès Bellanger

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors.
Lucia Parlati, Mehdi Sakka, Aurelia Retbi, Samir Bouam, Lamia Hassani, Agnès Bellanger

JHEP Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international comparative analysis and roadmap to sustainable biosimilar markets.
Khalid A Alnaqbi, Agnès Bellanger, Alex Brill, Gilberto Castañeda-Hernández, Ana Clopés Estela

Front Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs.
Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Effectiveness of cleaning of workplace cytotoxic surface.
Laetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yayé, André Rieutord, Agnès Bellanger

Int Arch Occup Environ Health· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Damien Roos-Weil, Nicolas Weiss, Amélie Guihot, Madalina Uzunov, Agnès Bellanger

J Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Hassane Sadou Yayé, Antoine Faucheron, Léa Dupont, Fadwa El Kouari, Arnaud Fekkar, Agnès Bellanger

Eur J Hosp Pharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab.
Madalina Uzunov, Sophie Demeret, Stéphanie Nguyen-Quoc, Véronique Morel, Agnès Bellanger

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
Hassane Sadou Yayé, Lamia Hassani, Philippe-Henri Secrétan, Martine Babiard, Haroun Aouati, Agnès Bellanger

J Pharm Biomed Anal· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Véronique Leblond, Agnès Bellanger

Rev Prat· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Véronique Leblond, Agnès Bellanger

Rev Prat· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High doses of biotin in chronic progressive multiple sclerosis: a pilot study.
Frédéric Sedel, Caroline Papeix, Agnès Bellanger, Valérie Touitou, Christine Lebrun-Frenay

Mult Scler Relat Disord· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of cleaning of workplace cytotoxic surface.
Laetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yaye, André Rieutord, Agnès Bellanger

Int Arch Occup Environ Health· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information].
Yasmine Hassani, Caroline Hochart, Lamia Hassani, Sophie Taillibert, Khe Hoang Xuan, Agnès Bellanger

Bull Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Jean-Christophe Corvol, Cécilia Bonnet, Fanny Charbonnier-Beaupel, Anne-Marie Bonnet, Marie-Hélène Fiévet, Agnès Bellanger

Ann Neurol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations.
Rabab Debs, Christel Depienne, Agnès Rastetter, Agnès Bellanger, Bertrand Degos

Arch Neurol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of oxaliplatin solution.
Audrey Junker, Sandrine Roy, Marie-Catherine Desroches, Clotilde Moussay, Malik Berhoune, Agnès Bellanger

Ann Pharmacother· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing patient perceptions of the side effects of cancer chemotherapy.
Nadége Carelle, Estelle Piotto, Agnés Bellanger, Jerome Germanaud, Alain Thuillier

Cancer· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis